Use of a Behavioral Economic Intervention to Reduce Antibiotic Prescription for Upper Respiratory Infections

计划入组 2,500 人 · 首次发布于 2018 年 3 月 14 日

Efficacy of Two Nasal Products Based on Diluted Seawater in the Treatment of Upper Respiratory Infections/Conditions

计划入组 89 人 · 首次发布于 2024 年 7 月 12 日

A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers

首次发布于 2014 年 8 月 26 日

anti-viroporin therapeutics (respiratory viral infections)

samRNA vaccine combination (multi-respiratory viral infections)

respiratory compound

Pneuma Respiratory, Inc.

United States

Japanese Respiratory Society

Japan

EUROPEAN RESPIRATORY SOCIETY

Spain

Sen-Jam's SJP-002C Shows Promise in Phase 2 Trial for COVID-19

Sen-Jam Pharmaceutical Completes Enrollment for Phase 2 Upper Respiratory Infection COVID Therapeutic

QIAGEN's QIAstat-Dx Respiratory Panel Mini Receives FDA Clearance for Outpatient Use